To investigate the effect of FUBP1 methylation on prostate cancer, we established FUBP1-depleted LNCaP and C4-2 cell lines and reintroduced wild-type FUBP1 or FUBP13K at physiologically relevant levels (Figure 3A). This evidence concerns the gene FUBP1 and prostate carcinoma.